Short Interest in DiaSorin S.p.A. (OTCMKTS:DSRLF) Declines By 8.6%

DiaSorin S.p.A. (OTCMKTS:DSRLFGet Free Report) saw a significant decline in short interest in November. As of November 30th, there was short interest totalling 35,100 shares, a decline of 8.6% from the November 15th total of 38,400 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Analyst Ratings Changes

Separately, UBS Group cut DiaSorin from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 26th.

Get Our Latest Report on DSRLF

DiaSorin Stock Down 0.3 %

Shares of DiaSorin stock opened at $106.85 on Tuesday. DiaSorin has a 52-week low of $105.88 and a 52-week high of $108.79. The firm’s 50 day moving average price is $104.87 and its 200-day moving average price is $102.91.

DiaSorin Company Profile

(Get Free Report)

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.

Featured Stories

Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.